LANXESS disinfectant effective against swine flu viral strain
New study from Giessen University
A recent study carried out on behalf of LANXESS has demonstrated the effectiveness of the disinfectant Preventol CD 601 against the swine flu viral strain. “The test results from Giessen University show that Preventol CD 601 can also play a major role in the fight against swine flu, which has now been classed as a pandemic. Our unique combination of three active ingredients has already proven extremely effective against other enveloped viruses such as the H5N1 bird flu virus,” says Dietmar Schlegel, market segment manager for disinfection in LANXESS’s Material Protection Products (MPP) business unit. The viral strain responsible for swine flu is an A viral strain (H1N1) from the Orthomyxoviridae family, which also includes bird flu.
In the next few months, the Business Unit Material Protection Products (MPP) expects significant growth for its active ingredients in the Disinfection & Personal Care segment.
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Bayer and X-Chem Expand Drug Discovery Collaboration to Discover Novel Medicines
Movetis wins two out of three categories at the PharmaVentures European Deals 2010 Awards
Clavis Pharma announces negative outcome of pivotal LEAP Trial with CP-4126 in Patients with Metastatic Pancreatic Cancer

DNA repair: Opening the hatch to heal the break

New drug candidates identified in bacteria - Bacteria show great promise as a source of active ingredients
